Cargando…

Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis

Sporadic inclusion body myositis (s-IBM) is characterized histologically by the association of concomitant inflammatory and degenerative processes. We evaluated the sensitivity and specificity of different markers of the degenerative process in order to refine the histological diagnosis. We performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubourg, O., Wanschitz, J., Maisonobe, T., Béhin, A., Allenbach, Y., Herson, S., Benveniste, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235833/
https://www.ncbi.nlm.nih.gov/pubmed/22106712
_version_ 1782218643369623552
author Dubourg, O.
Wanschitz, J.
Maisonobe, T.
Béhin, A.
Allenbach, Y.
Herson, S.
Benveniste, O
author_facet Dubourg, O.
Wanschitz, J.
Maisonobe, T.
Béhin, A.
Allenbach, Y.
Herson, S.
Benveniste, O
author_sort Dubourg, O.
collection PubMed
description Sporadic inclusion body myositis (s-IBM) is characterized histologically by the association of concomitant inflammatory and degenerative processes. We evaluated the sensitivity and specificity of different markers of the degenerative process in order to refine the histological diagnosis. We performed an immunohistochemical study with antibodies directed against ubiquitin, amyloid-β precursor protein (AβPP), amyloid-β (Aβ), SMI-31, SMI-310, Tar-DNA binding protein-43 (TDP-43) and p62 on s-IBM and control muscle biopsies. Based on conventional stains 36 patients with characteristic clinical features of s-IBM were subclassified as presumed definite s-IBM (d s-IBM, n = 17) or possible s-IBM (p s-IBM, n = 19) according to the presence or absence of vacuolated muscle fibers. Immunohistochemically, TDP-43 and p62 were the most sensitive markers, accumulating in all d s-IBM and in 31% and 37%, respectively, of the p s-IBM cases and thus enabling reclassification of these cases as d s-IBM. We recommend using TDP-43 and p62 antibodies in the histological diagnosis workup of s-IBM. The specificity of these markers has to be further validated in prospective series.
format Online
Article
Text
id pubmed-3235833
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Pacini Editore SpA
record_format MEDLINE/PubMed
spelling pubmed-32358332012-01-20 Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis Dubourg, O. Wanschitz, J. Maisonobe, T. Béhin, A. Allenbach, Y. Herson, S. Benveniste, O Acta Myol Articles in Tribute of V. Askanas and K. Engel Sporadic inclusion body myositis (s-IBM) is characterized histologically by the association of concomitant inflammatory and degenerative processes. We evaluated the sensitivity and specificity of different markers of the degenerative process in order to refine the histological diagnosis. We performed an immunohistochemical study with antibodies directed against ubiquitin, amyloid-β precursor protein (AβPP), amyloid-β (Aβ), SMI-31, SMI-310, Tar-DNA binding protein-43 (TDP-43) and p62 on s-IBM and control muscle biopsies. Based on conventional stains 36 patients with characteristic clinical features of s-IBM were subclassified as presumed definite s-IBM (d s-IBM, n = 17) or possible s-IBM (p s-IBM, n = 19) according to the presence or absence of vacuolated muscle fibers. Immunohistochemically, TDP-43 and p62 were the most sensitive markers, accumulating in all d s-IBM and in 31% and 37%, respectively, of the p s-IBM cases and thus enabling reclassification of these cases as d s-IBM. We recommend using TDP-43 and p62 antibodies in the histological diagnosis workup of s-IBM. The specificity of these markers has to be further validated in prospective series. Pacini Editore SpA 2011-10 /pmc/articles/PMC3235833/ /pubmed/22106712 Text en The journal and the individual contributions contained in it are protected by the copyright of Gaetano Conte Academy, Naples, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Articles in Tribute of V. Askanas and K. Engel
Dubourg, O.
Wanschitz, J.
Maisonobe, T.
Béhin, A.
Allenbach, Y.
Herson, S.
Benveniste, O
Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
title Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
title_full Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
title_fullStr Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
title_full_unstemmed Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
title_short Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
title_sort diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
topic Articles in Tribute of V. Askanas and K. Engel
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235833/
https://www.ncbi.nlm.nih.gov/pubmed/22106712
work_keys_str_mv AT dubourgo diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis
AT wanschitzj diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis
AT maisonobet diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis
AT behina diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis
AT allenbachy diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis
AT hersons diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis
AT benvenisteo diagnosticvalueofmarkersofmuscledegenerationinsporadicinclusionbodymyositis